10x Genomics, Inc. TXG
62.05 USD -0.85 (-1.35%)
At closeNov 12, 2026, 7:00 AM EST
61.32 -0.73 -1.17%
Pre-market · Nov 12, 7:00 AM ET
61.98 Day range 68.94
15.12 52-week range 102.81
- YTD
- +280.44%
- 1 year
- +271.78%
TXG revenue history
Revenue is income from the company’s ordinary business activities.
642,823,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 642,823,000 | 32,038,000 | 5.25% |
| FY 2024 | 2024-12-31 | 610,785,000 | -7,942,000 | -1.28% |
| FY 2023 | 2023-12-31 | 618,727,000 | 102,318,000 | 19.81% |
| FY 2022 | 2022-12-31 | 516,409,000 | 25,919,000 | 5.28% |
| FY 2021 | 2021-12-31 | 490,490,000 | 191,645,000 | 64.13% |
| FY 2020 | 2020-12-31 | 298,845,000 | 52,952,000 | 21.53% |
| FY 2019 | 2019-12-31 | 245,893,000 | 99,580,000 | 68.06% |
| FY 2018 | 2018-12-31 | 146,313,000 | 75,228,000 | 105.83% |
| FY 2017 | 2017-12-31 | 71,085,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-09T06:01:06.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.